A novel role for CD4+ T cells in the control of cachexia.
Cachexia is the dramatic weight loss and muscle atrophy seen in chronic disease states, including autoimmunity, cancer, and infection, and is often associated with lymphopenia. We have previously shown that CD4(+) T cells that express the lowest density of CD44 (CD4(+)CD44(v.low)) are significantly reduced in diabetic NOD mice that are cachexic compared with diabetic mice that are not cachexic. Using this model, and a model of cancer cachexia, we test the hypothesis that CD4(+)CD44(v.low) cells play an active role in protecting the host from cachexia. CD4(+)CD44(v.low) cells, but not CD4(+) cells depleted of CD44(v.low) cells, delay the onset of wasting when infused into either diabetic or prediabetic NOD recipients. However, no significant effect on the severity of diabetes was detected. In a model of cancer cachexia, they significantly reduce muscle atrophy, and inhibit muscle protein loss and DNA loss, even when given after the onset of cachexia. Protection from wasting and muscle atrophy by CD4(+)CD44(v.low) cells is associated with protection from lymphopenia. These data suggest, for the first time, a role for an immune cell subset in protection from cachexia, and further suggest that the mechanism of protection is independent of protection from autoimmunity.
Wang
Zhuangzhi
Z
Torrey Pines Institute for Molecular Studies, San Diego, CA 92121, USA.
Zhao
Chunfang
C
Moya
Rosa
R
Davies
Joanna D
JD
D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology* / Q000378:metabolism / Q000637:transplantation*; D002100:Cachexia / Q000276:immunology* / Q000517:prevention & control / Q000628:therapy*; D018827:Carcinoma, Lewis Lung; D045744:Cell Line, Tumor; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis / Q000276:immunology; D005260:Female; D018960:Hyaluronan Receptors / Q000008:administration & dosage / Q000096:biosynthesis; D015994:Incidence; D008231:Lymphopenia / Q000276:immunology / Q000628:therapy; D051379:Mice; D008810:Mice, Inbred C57BL; D016688:Mice, Inbred NOD; D009133:Muscular Atrophy / Q000276:immunology / Q000517:prevention & control; D009368:Neoplasm Transplantation; D012720:Severity of Illness Index; D016176:T-Lymphocyte Subsets / Q000276:immunology / Q000378:metabolism / Q000637:transplantation; D019282:Wasting Syndrome / Q000276:immunology / Q000628:therapy
D018960:Hyaluronan Receptors
Am J Clin Nutr. 2006 Dec;84(6):1463-72
17158431
Nat Immunol. 2003 Apr;4(4):330-6
12612578
Anticancer Res. 2002 Sep-Oct;22(5):2547-54
12529962
Anal Biochem. 1983 Jun;131(2):538-47
6193739
Int J Cardiol. 2002 Sep;85(1):15-21
12163206
Endocrinology. 2000 Jul;141(7):2508-17
10875252
Int J Cancer. 1995 May 16;61(4):522-8
7759158
Nutrition. 2008 Apr;24(4):305-13
18262758
Cancer Res. 1991 Jul 1;51(13):3590-4
2054795
J Immunol. 2005 May 15;174(10):6039-44
15879097
Cancer Res. 1995 Feb 15;55(4):921-7
7850809
Diabetes Metab Rev. 1988 Dec;4(8):751-72
3148443
Drugs Aging. 1997 Nov;11(5):374-97
9359024
J Clin Invest. 1995 Jun;95(6):2926-37
7769135
Mech Ageing Dev. 1999 May 17;108(3):183-206
10405980
J Clin Invest. 1990 Jan;85(1):185-91
2104878
Int Immunol. 1993 Nov;5(11):1461-71
7903159
Biogerontology. 2002;3(1-2):19-24
12014835
Development. 1993 May;118(1):33-46
8104143
J Exp Med. 2004 May 17;199(10):1401-8
15148338
J Immunol. 2003 Jul 1;171(1):61-8
12816983
J Exp Med. 1986 Jun 1;163(6):1433-50
3486936
Semin Immunol. 1997 Dec;9(6):347-53
9405263
Adv Immunol. 1992;51:285-322
1323922
Proc Natl Acad Sci U S A. 1989 Sep;86(17):6734-8
2528147
Crit Rev Oncog. 1998;9(2):99-106
9973244
Immunity. 1994 Oct;1(7):543-52
7600283
Biogerontology. 2005;6(3):193-204
16041623
J Gerontol. 1994 Nov;49(6):B255-62
7525689
Annu Rev Biochem. 1989;58:875-911
2673025
FASEB J. 2004 Jan;18(1):39-51
14718385
Nat Rev Immunol. 2002 Jun;2(6):389-400
12093005
Ann N Y Acad Sci. 1989;569:211-8
2698089
J Exp Med. 2007 Jul 9;204(7):1665-75
17591857
Birth Defects Orig Artic Ser. 1975;11(1):173-84
1096977
Semin Oncol. 1998 Apr;25(2 Suppl 6):76-81
9625388
Immunology. 1999 Apr;96(4):600-5
10233747
J Support Oncol. 2007 Mar;5(3):119-25, 128
17410810
Am J Clin Nutr. 1997 Mar;65(3):876-82
9062543
Eur Respir J. 2008 Mar;31(3):492-501
18310396
Immunol Rev. 2006 Jun;211:154-63
16824125
Diabetes. 2007 May;56(5):1395-402
17317763
FASEB J. 1997 Aug;11(10):775-83
9271362
J Clin Oncol. 2004 Jun 15;22(12):2469-76
15197210
Immunol Rev. 1996 Feb;149:97-125
9005222
J Immunol. 1987 May 15;138(10):3120-9
3106474
Immunol Today. 1993 Jan;14(1):25-9
8442858
J Nutr. 1998 Feb;128(2 Suppl):323S-327S
9478016
Annu Rev Immunol. 1990;8:647-79
2188676
Cancer Res. 1997 Jan 1;57(1):94-9
8988047
Immunity. 1999 Aug;11(2):173-81
10485652
J Immunol. 2017 Feb 1;198(3):981-985
28115586
J Immunol. 1999 Jan 15;162(2):711-7
9916690
J Immunol. 1990 Mar 15;144(6):2216-22
2107255
Semin Immunol. 1997 Dec;9(6):339-46
9405262
Cell. 1996 May 3;85(3):291-7
8616883
Immunity. 2000 Apr;12(4):431-40
10795741
Jikken Dobutsu. 1980 Jan;29(1):1-13
6995140
Br J Cancer. 2002 Mar 18;86(6):1012-6
11953838
Nature. 2001 Apr 19;410(6831):980-7
11309628
Res Immunol. 1995 Jan;146(1):23-34
7569310
Baillieres Clin Endocrinol Metab. 1996 Oct;10(4):589-601
9022953
Clin Nutr. 2007 Aug;26(4):389-99
17499396
Ann Surg. 2001 Jan;233(1):9-17
11141219
Immunology. 2008 Sep;125(1):48-58
18397274
J Immunol. 1990 May 1;144(9):3288-95
1970350
J Clin Invest. 1992 May;89(5):1681-4
1569207
Clin Nutr. 2007 Oct;26(5):614-8
17688974
Eur J Immunol. 1989 Apr;19(4):617-23
2567241
Br J Haematol. 1993 Jul;84(3):374-80
8217788
J Immunol. 1990 Apr 1;144(7):2811-5
2319135
Am J Clin Nutr. 2006 Jun;83(6):1345-50
16762946
Scand J Immunol. 2002 Sep;56(3):323-6
12193235
J Clin Oncol. 2006 Apr 20;24(12):1852-9
16622259
Osaka City Med J. 1999 Jun;45(1):25-35
10723199
Life Sci. 1994;55(15):1163-77
7934613
J Exp Med. 2003 Feb 17;197(4):451-60
12591903
Proc Natl Acad Sci U S A. 2004 Mar 16;101(11):3874-9
15001705